Fischl M, Mollan K, Pahwa S, et al. IRIS among US subjects starting ART in AIDS Clinical Trials Group study A5202. Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, California. Abstract 791.